Myelodysplasia Research and Clinical Trials

City of Hope is a recognized leader in myelodysplasia research with more than three decades of experience. Our research projects have been funded by the National Cancer Institute (NCI) and many other research-based organizations, and our scientists collaborate with other leading research institutions to develop tomorrow’s breakthroughs today.
 
  • City of Hope is studying methods to minimize risk and severity of graft-versus-host disease (GvHD) for myelodysplasia patients who had undergone an allogeneic stem cell transplant, including use of immunosuppressants and developing a better process of matching donors to recipients.
  • Developing a safe and effective stem cell transplantation protocol for HIV-positive patients with myelodysplastic syndrome.
  • Investigating the biological mechanisms that transform myelodysplasia into leukemia and how those processes can be halted.
  • Looking into ways to minimize risk of developing secondary myelodysplastic syndrome resulting from current cancer treatments.
 
Patients and physicians can access Clinical Trials On-Line to find out about myelodysplasia clinical trials that are currently being conducted at City of Hope or visit our clinical trials information page.
 
 
If you have been diagnosed with a myelodysplastic syndrome disorder or are looking for a second opinion consultation about your treatment, find out more about becoming a patient or contact us at 800-826-HOPE.